A patent landscape analysis of 22 common genetic diagnostic tests shows substantially fewer claims on genes per se than initially suggested but raises questions of legal uncertainty as to the claims' scope.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1038/nbt1009-903 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!